CSIMarket
 
Indivior Pharmaceuticals Inc   (NASDAQ: INDV)
 

Indivior Pharmaceuticals Inc's Customers Performance

INDV



 
INDV's Source of Revenues During the corresponding time, Indivior Pharmaceuticals Inc recorded a revenue increase by 13.58 % year on year, sequentially revenue grew by 8.2 %. While revenue at the Indivior Pharmaceuticals Inc 's corporate clients

List of INDV Customers




for the same period Indivior Pharmaceuticals Inc recorded revenue increase by 13.58 % year on year, sequentially revenue grew by 8.2 %.

List of INDV Customers

Indivior Pharmaceuticals Inc's Business Units
Reportable    141.69 % of total Revenue






Indivior Pharmaceuticals Inc's Comment on Sales, Marketing and Customers



Pharmaceutical companies operate within a regulatory framework governed by U.S. federal laws addressing fraud, abuse, and transparency in healthcare. These companies engage with patients, prescribers, purchasers, and formulary managers, and their activities are subject to statutes such as the Anti-Kickback Statute, the False Claims Act, and the Health Insurance Portability and Accountability Act (HIPAA). These laws regulate arrangements and transactions involving referrals, prescriptions, and payments under Medicare, Medicaid, and other federally funded healthcare programs, as well as private third-party payors and healthcare benefit programs. Violations of these laws can result in penalties including fines, damages, imprisonment, and exclusion from federal healthcare programs.





Indivior Pharmaceuticals Inc’s Comment on Sales, Marketing and Customers


Pharmaceutical companies operate within a regulatory framework governed by U.S. federal laws addressing fraud, abuse, and transparency in healthcare. These companies engage with patients, prescribers, purchasers, and formulary managers, and their activities are subject to statutes such as the Anti-Kickback Statute, the False Claims Act, and the Health Insurance Portability and Accountability Act (HIPAA). These laws regulate arrangements and transactions involving referrals, prescriptions, and payments under Medicare, Medicaid, and other federally funded healthcare programs, as well as private third-party payors and healthcare benefit programs. Violations of these laws can result in penalties including fines, damages, imprisonment, and exclusion from federal healthcare programs.








INDV's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Indivior Pharmaceuticals Inc 4,259.40 1,292.00 252.00 1,000
SUBTOTAL 0.00 0.00 0.00 -

Sources: Indivior Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Indivior Pharmaceuticals Inc’s corporate clients.
For your research, we’ve provided 9 tables on Indivior Pharmaceuticals Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.